PadPro(R) Adult Radiotransparent Multifunction Electrodes, REF/Catalog No. 2001M-C. The PadPr...

FDA Device Recall #Z-1317-2013 — Class II — May 3, 2013

Recall Summary

Recall Number Z-1317-2013
Classification Class II — Moderate risk
Date Initiated May 3, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm ConMed Corporation
Location Utica, NY
Product Type Devices
Quantity Domestic: 49,010; Foreign: 600

Product Description

PadPro(R) Adult Radiotransparent Multifunction Electrodes, REF/Catalog No. 2001M-C. The PadPro(R) Adult Radiotransparent Multifunction Electrodes with Carbon Leadwires and Medtronic(R) Connector are intended to be used in external pacing, defibrillation and monitoring applications

Reason for Recall

ConMed was notified by the contract manufacturer that their wire/connector supplier reported damage to the connector tooling which could pinch or compress the lead wire filaments and potentially render the device incapable of delivering the appropriate energy or shock to the patient and/or could cause potential injury to user or patient.

Distribution Pattern

Worldwide distribution: USA (nationwide) and the country of: Saudi Arabia.

Lot / Code Information

Lot Code Y092012-21, Manufacture Date 10/10/2012; Lot Code Y102612-12, Manufacture Date 11/17/2012; Lot Code Y110912-20, Manufacture Date 11/30/2012; Lot Code Y112912-10, Manufacture Date 12/22/2012; Lot Code Y121312-19, Manufacture Date 01/03/2013; Lot Code Y011013-13, Manufacture Date 01/29/2013; Lot Code Y012513-02, Manufacture Date 02/12/2013; Lot Code Y020713-05, Manufacture Date 02/26/2013; Lot Code Y021413-03, Manufacture Date 03/07/2013; Lot Code Y030113-04, Manufacture Date 03/23/2013

Other Recalls from ConMed Corporation

Recall # Classification Product Date
Z-0474-2023 Class II Foot Controlled Electrosurgical Suction Coagula... Nov 18, 2022
Z-1498-2021 Class II INFINITY_TRAY Custom Procedural Kit - Canada. ... Mar 26, 2021
Z-1499-2021 Class II KIT_INFINITY_BASE Custom Procedural Kit - Italy... Mar 26, 2021
Z-0650-2021 Class II Infinity ACL Tibial Elbow Guide-indicated for u... Nov 12, 2020
Z-0651-2021 Class II Infinity ACL Tibial Tip Guide- indicated for u... Nov 12, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.